Brief: Engene Holdings - Closed A $200 Million Oversubscribed Private Financing, Expected To Extend Cash Runway Into 2027

enGene Therapeutics

11/03/2024 22:33

March 11 (Reuters) - enGene Holdings Inc  ENGN.O :
    * ENGENE HOLDINGS - CLOSED A $200 MILLION OVERSUBSCRIBED
PRIVATE
FINANCING, EXPECTED TO EXTEND CASH RUNWAY INTO 2027
    * ENGENE-PIVOTAL PHASE 2 LEGEND STUDY OF EG-70 IN
BCG-UNRESPONSIVE
NON-MUSCLE INVASIVE BLADDER CANCER ON TRACK WITH INTERIM DATA
ANTICIPATED IN MID-2024

Source text for Eikon:  ID:n0000950170-24-029396 
Further company coverage:  ENGN.O